Emergent BioSolutions Inc. (NYSE:EBS) declared that it has submitted a offering in salutation to a letter for offering (RFP) issued by the U.S. Department of Health and Human Services (HHS) for a recombinant conserving antigen Bacilli immunogen (rPA). Emergent’s rPA immunogen politician is a reformulated and more steady modify of the rPA 102 immunogen originally matured at the U.S.

Tags: Department Of Health, Health, Proposal